Therapeutic Area | MeSH |
---|---|
hemic and lymphatic diseases | D006425 |
nutritional and metabolic diseases | D009750 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
FOLVRON | Lederle Laboratories | N-006012 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
allevia | unapproved drug other | 2025-02-27 |
animi-3 | unapproved drug other | 2013-02-06 |
bal-care dha | unapproved drug other | 2012-05-01 |
bal-care dha essential | unapproved drug other | 2012-05-01 |
beautyturess turmeric vitamin c peel-off mask | C200263 | 2024-10-13 |
body prescriptions hand sanitizer moisturizing with vitamin e | OTC monograph not final | 2020-06-01 |
bp vit 3 | unapproved drug other | 2025-02-13 |
c-nate dha | unapproved drug other | 2024-01-22 |
ccc clean corrective with vitamin c tinted moisturizer broad spectrum spf 30 | C200263 | 2023-12-05 |
centratex | unapproved drug other | 2024-01-31 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colorectal neoplasms | D015179 | — | — | — | 12 | 8 | 1 | 1 | 22 |
Neoplasms | D009369 | — | C80 | 2 | 2 | 7 | 1 | 1 | 12 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 1 | 2 | 4 | 2 | — | 9 |
Hepatitis | D006505 | — | K75.9 | — | — | 3 | 1 | 2 | 6 |
Hepatitis a | D006506 | EFO_0007305 | B15 | — | — | 3 | 1 | 2 | 6 |
Hepatitis c | D006526 | — | B19.2 | — | — | 3 | 1 | 1 | 5 |
Infections | D007239 | EFO_0000544 | — | — | — | — | 1 | 1 | 2 |
Communicable diseases | D003141 | — | — | — | — | — | 1 | 1 | 2 |
Cytomegalovirus infections | D003586 | EFO_0001062 | B25 | — | — | — | 1 | — | 1 |
Sepsis | D018805 | EFO_0001420 | A41.9 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | 3 | 1 | — | — | 4 |
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | — | — | 3 | — | 1 | 4 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | — | 3 | — | — | 3 |
Colonic neoplasms | D003110 | — | C18 | — | 1 | 1 | — | — | 2 |
Macular degeneration | D008268 | EFO_0001365 | H35.30 | — | — | 1 | — | 1 | 2 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | 1 | — | — | 1 |
Melanoma | D008545 | — | — | — | — | 1 | — | — | 1 |
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | 1 | — | — | 1 |
Fibrosis | D005355 | — | — | — | — | 1 | — | — | 1 |
Sclerosis | D012598 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Rectal neoplasms | D012004 | — | — | — | 3 | — | — | — | 3 |
Adenocarcinoma | D000230 | — | — | 1 | 3 | — | — | — | 3 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | 2 | — | — | — | 2 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | 2 | — | — | — | 2 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | — | 2 | — | — | — | 2 |
Lymphoma | D008223 | — | C85.9 | — | 2 | — | — | — | 2 |
Esophageal neoplasms | D004938 | — | C15 | 1 | 1 | — | — | — | 1 |
Non-small-cell lung carcinoma | D002289 | — | — | — | 1 | — | — | — | 1 |
Follicular lymphoma | D008224 | — | C82 | — | 1 | — | — | — | 1 |
Carcinoma | D002277 | — | C80.0 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Alzheimer disease | D000544 | EFO_0000249 | F03 | 1 | — | — | — | 1 | 2 |
Covid-19 | D000086382 | — | U07.1 | 1 | — | — | — | — | 1 |
Myeloid leukemia | D007951 | — | C92 | 1 | — | — | — | — | 1 |
Bronchiolitis obliterans syndrome | D000092122 | — | D89.811 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | — | — | 3 | 3 |
Human influenza | D007251 | EFO_0007328 | J11.1 | — | — | — | — | 2 | 2 |
Heart failure | D006333 | EFO_0003144 | I50 | — | — | — | — | 2 | 2 |
Hepatitis b | D006509 | — | — | — | — | — | — | 1 | 1 |
Chronic hepatitis b | D019694 | EFO_0004239 | B18.1 | — | — | — | — | 1 | 1 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | — | — | 1 | 1 |
Hemorrhage | D006470 | MP_0001914 | R58 | — | — | — | — | 1 | 1 |
Endometrial neoplasms | D016889 | EFO_0004230 | — | — | — | — | — | 1 | 1 |
Uterine hemorrhage | D014592 | — | — | — | — | — | — | 1 | 1 |
Postmenopause | D017698 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Folic acid |
INN | folic acid |
Description | Folate, also known as vitamin B9 and folacin, is one of the B vitamins. Manufactured folic acid, which is converted into folate by the body, is used as a dietary supplement and in food fortification as it is more stable during processing and storage. Folate is required for the body to make DNA and RNA and metabolise amino acids necessary for cell division. As the human body cannot make folate, it is required in the diet, making it an essential nutrient. It occurs naturally in many foods. The recommended adult daily intake of folate in the U.S. is 400 micrograms from foods or dietary supplements.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1 |
PDB | — |
CAS-ID | 59-30-3 |
RxCUI | — |
ChEMBL ID | CHEMBL1622 |
ChEBI ID | 27470 |
PubChem CID | 6037 |
DrugBank | DB00158 |
UNII ID | 935E97BOY8 (ChemIDplus, GSRS) |